AIM To assess the effect of artificial liver support system (ALSS) on patients with severe viral hepatitis, who were divided into treatment group and control group. METHODS Four hundred in-hospital patients enrolled during 1995-2003 who received ALSS therapy were studied as the treatment group. Four hundred in-hospital patients enrolled during 1986-1994 who received other medical therapies served as the control group. The methods of ALSS used included plasma exchange, hemoperfusion, hemofiltration, continuous hemodiafiltration (CHDF). The effect of ALSS treatment was studied in patients at different stages of the disease. RESULTS The cure rate of acute and subacute severe hepatitis in the treatment group was 78.9% (30/38), and was 11.9% (5/42) in the control group. The improved rate of chronic severe hepatitis in the treatment group was 43.4% (157/362), and was 15.4% (55/358) in the control group. We found that patients treated with ALSS in the early or middle stage of the disease had much higher survival rates than patients in the end stage of the disease. CONCLUSION ALSS is an effective and safe therapy for severe viral hepatitis.
Effect of artificial liver support system on patients with severe viral hepatitis: a study of four hundred cases.
Lan-juan Li,Qian Yang,Jian-rong Huang,Xiaowei Xu,Yuemei Chen,S. Fu
Published 2004 in World Journal of Gastroenterology
ABSTRACT
PUBLICATION RECORD
- Publication year
2004
- Venue
World Journal of Gastroenterology
- Publication date
2004-10-15
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-28 of 28 references · Page 1 of 1
CITED BY
Showing 1-33 of 33 citing papers · Page 1 of 1